Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare Inks Deal to Offer AccuRef Reference Materials

NEW YORK (GenomeWeb) — SeraCare Life Sciences announced today that it has signed an agreement under which it will offer AccuRef Diagnostics' line of CRISPR-engineered cell line reference materials.

Under the terms of the deal, Milford, Massachusetts-based SeraCare will market and sell AccuRef's portfolio of CRISPR-engineered cell line-based cancer reference materials beginning in January in all markets except for China. The deal includes products geared for low-to-mid plex clinical genomic applications such as qPCR, digital PCR, Sanger sequencing, mass spec, and small targeted next-generation sequencing gene panels.

Additional terms were not disclosed.

AccuRef — a Milpitas, California-based division of global molecular and cellular reference standards provider Applied StemCell — was established last year.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.